Skip to main content
. 2018 Oct 18;19(8):3670–3680. doi: 10.1208/s12249-018-1183-0

Table I.

List of FDA-Approved Nucleic Acid Products

Drug name Active ingredient Year Therapeutic agent Indication Route Vehicle Company
Vitravene Fomivirsen 1998 Antisense oligonucleotide Cytomegalovirus retinitis Intravitreal injection None Isis Pharmaceuticals
Macugen Pegatanib 2004 Aptamer Age-related macular degeneration Intravitreal injection None Eyetech Inc.
Kynamro Mipomersen 2013 Antisense oligonucleotide Homozygous familial hypercholesterolemia Subcutaneous injection None Genzyme Corporation
Exondys 51 Eteplirsen 2016 Antisense oligonucleotide Duchenne muscular dystrophy Intravenous infusion None Sarepta Therapeutics
Spinraza Nusinersen 2016 Antisense oligonucleotide Spinal muscular atrophy Intrathecal injection None Biogen Inc.
Defitelio Defibrotide 2016 Oligonucleotide with profibrinolytic properties Sinusoidal obstruction syndrome Intravenous infusion None Jazz Pharmaceuticals, Inc.
Onpattro Patisiran 2018 Small interference RNA Polyneuropathy of hereditary transthyretin-mediated amyloidosis Intravenous infusion Lipid complex Alnylam Pharma Inc.